We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
2876
Scholar Rock
SRRK
$6.44B
$564K ﹤0.01%
42,741
-14,182
-25% -$136K
GNTY
2877
DELISTED
Guaranty Bancshares
GNTY
$557K ﹤0.01%
18,645
-9,996
-35% -$291K
EGAN icon
2878
eGain
EGAN
$201M
$556K ﹤0.01%
70,219
-178,346
-72% -$1.38M
GEOS icon
2879
Geospace Technologies
GEOS
$75.7M
$554K ﹤0.01%
33,086
-83
-0.3% -$1.26K
CNBKA
2880
DELISTED
Century Bancorp Inc/Mass
CNBKA
$552K ﹤0.01%
6,135
-5,194
-46% -$454K
MPX
2881
DELISTED
Marine Products Corp
MPX
$550K ﹤0.01%
38,195
-501
-1% -$7.25K
VFL
2882
DELISTED
abrdn National Municipal Income Fund
VFL
$550K ﹤0.01%
41,405
ABEO icon
2883
Abeona Therapeutics
ABEO
$413M
$546K ﹤0.01%
6,674
-193
-3% -$13.6K
GWRS icon
2884
Global Water Resources
GWRS
$219M
$546K ﹤0.01%
41,525
-250
-0.6% -$3.14K
SBT
2885
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$546K ﹤0.01%
67,410
MR
2886
DELISTED
Montage Resources Corporation Common Stock
MR
$546K ﹤0.01%
68,789
-160,429
-70% -$837K
PLSE icon
2887
Pulse Biosciences
PLSE
$3.02B
$544K ﹤0.01%
40,610
ACTG icon
2888
Acacia Research
ACTG
$470M
$539K ﹤0.01%
202,926
RUSHB icon
2889
Rush Enterprises Class B
RUSHB
$6.14B
$534K ﹤0.01%
26,312
-20,313
-44% -$394K
FVCB icon
2890
FVCBankcorp
FVCB
$333M
$530K ﹤0.01%
37,938
-612
-2% -$8.47K
TCRR
2891
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$530K ﹤0.01%
37,051
+7,021
+23% +$109K
TCP
2892
DELISTED
TC Pipelines LP
TCP
$530K ﹤0.01%
12,540
-1,161
-8% -$45.9K
OCUL icon
2893
Ocular Therapeutix
OCUL
$2.02B
$527K ﹤0.01%
133,488
-58,343
-30% -$203K
ELVT
2894
DELISTED
Elevate Credit, Inc.
ELVT
$527K ﹤0.01%
118,410
+32,170
+37% +$134K
CBMG
2895
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$527K ﹤0.01%
32,472
-79
-0.2% -$1.32K
CLFD icon
2896
Clearfield
CLFD
$374M
$524K ﹤0.01%
37,603
WPP icon
2897
WPP
WPP
$5.94B
$524K ﹤0.01%
7,458
-30,427
-80% -$1.93M
SCWX
2898
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$523K ﹤0.01%
31,411
NBH
2899
Neuberger Municipal Fund Inc
NBH
$304M
$517K ﹤0.01%
33,556
CASA
2900
DELISTED
Casa Systems, Inc. Common Stock
CASA
$509K ﹤0.01%
124,401
-9,256
-7% -$44.2K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.